Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP164933.RA29JhiUqNsL56QZn_sbnG4--O6RLp4bwoinNUJF2Jw_o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP164933.RA29JhiUqNsL56QZn_sbnG4--O6RLp4bwoinNUJF2Jw_o130_assertion type Assertion NP164933.RA29JhiUqNsL56QZn_sbnG4--O6RLp4bwoinNUJF2Jw_o130_head.
- NP164933.RA29JhiUqNsL56QZn_sbnG4--O6RLp4bwoinNUJF2Jw_o130_assertion description "[We studied HCV-positive subjects with chronic liver diseases treated with pegylated-interferon (PEG-IFN) and ribavirin (RBV) who failed to clear HCV in routine clinical practice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP164933.RA29JhiUqNsL56QZn_sbnG4--O6RLp4bwoinNUJF2Jw_o130_provenance.
- NP164933.RA29JhiUqNsL56QZn_sbnG4--O6RLp4bwoinNUJF2Jw_o130_assertion evidence source_evidence_literature NP164933.RA29JhiUqNsL56QZn_sbnG4--O6RLp4bwoinNUJF2Jw_o130_provenance.
- NP164933.RA29JhiUqNsL56QZn_sbnG4--O6RLp4bwoinNUJF2Jw_o130_assertion SIO_000772 19780939 NP164933.RA29JhiUqNsL56QZn_sbnG4--O6RLp4bwoinNUJF2Jw_o130_provenance.
- NP164933.RA29JhiUqNsL56QZn_sbnG4--O6RLp4bwoinNUJF2Jw_o130_assertion wasDerivedFrom befree-20140225 NP164933.RA29JhiUqNsL56QZn_sbnG4--O6RLp4bwoinNUJF2Jw_o130_provenance.
- NP164933.RA29JhiUqNsL56QZn_sbnG4--O6RLp4bwoinNUJF2Jw_o130_assertion wasGeneratedBy ECO_0000203 NP164933.RA29JhiUqNsL56QZn_sbnG4--O6RLp4bwoinNUJF2Jw_o130_provenance.